gdc

June 2018 Cancer Immunotherapy

Immunotherapy Changing the Face of Cancer Care
ImmunotherapyIssue Introductions
New developments in immunotherapy drugs continue to create buzz in the cancer community and beyond. This special issue discusses key developments in immunotherapy, highlighting new advances and providing resources for patients, their family members, and their oncology navigators.
Immune Checkpoint Inhibitors Offer New Hope for Patients with Lung Cancer
ImmunotherapyLung Cancer
Several immune checkpoint inhibitors are now approved for patients with non-small-cell lung cancer, giving hope to patients living with this disease.
CAR T-Cell Therapy a Promising Option for Patients with Certain Types of B-Cell Lymphoma
ImmunotherapyLymphoma
“CAR T-cell therapy provides an exciting and additional option for patients who have failed more traditional regimens,” says Dr. Gwen Nichols, Chief Medical Officer for Leukemia & Lymphoma Society.
First National Guidelines for Dealing with Side Effects of Immune Checkpoint Inhibitors
ImmunotherapySide-Effects Management
The National Comprehensive Cancer Care Network and the American Society of Clinical Oncology recently issued the first set of recommendations for the management of immunotherapy side-effects.
There Will Be Dark Days
Art Therapy
Alisa Lehman’s art depicts cancer as a monster holding her captive in a cage. She recently joined an immunotherapy clinical trial after her medication for metastatic breast cancer stopped working.
Can I Keep My Job? Avoiding Lost Income and Productivity as a Cancer Survivor
SurvivorshipWork and Cancer
Cancer treatment costs, and the desire for normalcy and self-worth, are some of the reasons why patients with cancer wish to remain in the workforce.

Results 1 - 7 of 7

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country